Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumor agents

Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumor agents

US Patent 6114332 · Granted Sep 5, 2000

Estimated economic value: $485,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tricyclic heterocyclic derivatives and uses thereof2021
1-(Chloromethyl)-2,3-dihydro-1H-benzo[e]indole dimer antibody-drug conjugate com2020
1-(chloromethyl)-2,3-dihydro-1H-benzo[E]indole dimer antibody-drug conjugate com2019
Ketamine derivatives2019
Perforin inhibiting benzenesulfonamide compounds, preparation and uses thereof2018
Perforin inhibiting benzenesulfonamide compounds, preparation and uses thereof2018
Nitroimidazooxazines and their uses in anti-tubercular therapy2015
Kinase inhibitors, prodrug forms thereof and their use in therapy2015
Prodrug forms of kinase inhibitors and their use in therapy2015
Nitroimidazooxazine and nitroimidazooxazole analogues and their uses2012
Tricyclic 1,2,4-triazine oxides and compositions for therapeutic use in cancer t2011
Quinoline derivatives for modulating DNA methylation2011